
    
      PRIMARY OBJECTIVES:

      I. To determine which drug has the greatest effect on Ang-(1-7) levels in cancer patients
      with hypertension.

      SECONDARY OBJECTIVES:

      I. To determine the effect of these drugs on levels of Ang II, VEGF, PlGF, and ACE in the
      same patients.

      OUTLINE: Patients are randomized to 1 of 4 treatment arms.

        -  ARM I: Patients receive oral benazepril hydrochloride once daily on days 1-7.

        -  ARM II: Patients receive oral lisinopril once daily on days 1-7.

        -  ARM III: Patients receive oral ramipril twice daily on days 1-7.

        -  ARM IV: Patients receive oral losartan potassium once daily on days 1-7. In all arms,
           treatment continues in the absence of unacceptable toxicity.
    
  